Michael C. Cameron

Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trial

Andrew Blauvelt, Jonathan I. Silverberg, Charles Lynde et al. · Journal of the American Academy of Dermatology · 2021 · 140 citations · Full text

Phase 3 efficacy and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab (JADE EXTEND)

Vivian Y. Shi, Tina Bhutani, Luz Fonacier et al. · Journal of the American Academy of Dermatology · 2022 · 89 citations · Full text

Gap characteristics and replacement patterns in the Knysna Forest, South Africa

Jeremy J. Midgley, Michael C. Cameron, William J. Bond · Journal of Vegetation Science · 1995 · 61 citations

Engineering, Forest Restoration, Forestry +19

Morphologic integration of hilar ectopic granule cells into dentate gyrus circuitry in the pilocarpine model of temporal lobe epilepsy

Michael C. Cameron, Ren‐Zhi Zhan, J. Victor Nadler · The Journal of Comparative Neurology · 2011 · 56 citations · Full text

Neurotransmitter, Normotopic Granule Cells, Temporal Lobe Epilepsy +20

Suprascapular neuropathy after intensive progressive resistive exercise: case report.

James C. Agre, Nachman Ash, Michael C. Cameron et al. · PubMed · 1987 · 55 citations